Vistagen CFO Cynthia Anderson resigns effective Oct 15; annual meeting votes ratified

Vistagen Therapeutics, Inc.

CFO Cynthia L. Anderson resigns effective Oct 15, 2025; resignation not due to any disagreement with company.
Company is searching for a successor; intends to enter a consulting agreement with Anderson for transition support.
Six director nominees elected at annual meeting, including CEO Shawn Singh and Chair Margaret FitzPatrick.
Non-binding advisory vote on executive compensation (say-on-pay) approved by stockholders.
Appointment of KPMG as independent auditor for fiscal year ending March 31, 2026 ratified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.